In-vitro Diagnostics for Cardiology and Neurology Market Segmentation:
Product & Service Segment Analysis
Reagents & kits are expected to acquire the highest share of 55.4% in the in-vitro diagnostics for cardiology and neurology market by the end of 2035. The leadership is largely backed by the increasing demand for regular testing of CVD, particularly biomarkers such as troponin for heart attacks. Substantial consumption in this category is further encouraged and fueled by the emergence of POC testing. Evidencing the same, the Observatory of Economic Complexity (OEC) reported that the value of globally traded other diagnostic reagents accounted for USD 38.3 billion in 2023 alone.
Technology Segment Analysis
Point-of-care testing (POCT) is estimated to account for a considerable share of 22.9% in the in-vitro diagnostics for cardiology and neurology market over the assessed period. The growing importance in delivering rapid and accessible diagnostic results are facilitating a notable momentum in this segment. POCT technologies, being a gold standard for healthcare service providers to perform critical tests near the patient, are becoming a mainstream practice in a majority of pathological laboratories, especially in emergency and outpatient settings. Moreover, the convenience, reduced turnaround time, and ability to operate in decentralized locations are key factors driving the adoption and expansion of POCT in this sector.
End user Segment Analysis
Hospitals are predicted to continue dominating the in-vitro diagnostics for cardiology and neurology market with a 45.6% share during the analyzed timeline. Due to having specialized in-house departments, workforce, and infrastructure, these facilities are considered as the primary point of contact for patients worldwide. Particularly, their ability to handle complex and emergency cases, requiring accessible, rapid, and reliable diagnosis, contribute to their dominance in this field. Furthermore, the rising volume of hospitalizations that seek continuous patient monitoring and wide availability of public reimbursements, position hospitals as the biggest consumer base in the market.
Our in-depth analysis of the in-vitro diagnostics for cardiology and neurology market includes the following segments:
|
Segment |
Subsegments |
|
Product & Service |
|
|
Technology |
|
|
Test Location |
|
|
Application |
|
|
End user |
|
